Viraclear Eps 7630 Cherry Flavor

Pelargonium Sidoides


Schwabe North America, Inc
Human Otc Drug
NDC 59800-8002
Viraclear Eps 7630 Cherry Flavor also known as Pelargonium Sidoides is a human otc drug labeled by 'Schwabe North America, Inc'. National Drug Code (NDC) number for Viraclear Eps 7630 Cherry Flavor is 59800-8002. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Viraclear Eps 7630 Cherry Flavor drug includes Pelargonium Sidoides Root - 1 [hp_X]/120mL . The currest status of Viraclear Eps 7630 Cherry Flavor drug is Active.

Drug Information:

Drug NDC: 59800-8002
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Viraclear Eps 7630 Cherry Flavor
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Pelargonium Sidoides
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Schwabe North America, Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:PELARGONIUM SIDOIDES ROOT - 1 [hp_X]/120mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 24 Aug, 2009
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 24 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Schwabe North America, Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0359800800250
UPC stands for Universal Product Code.
UNII:H6J53HEX8E
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
59800-8002-51 BOTTLE, DROPPER in 1 CARTON (59800-8002-5) / 120 mL in 1 BOTTLE, DROPPER24 Aug, 2009N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose shortens duration and reduces severity of symptoms associated with common colds and throat/nasal/bronchial irritations: congestion, cough, headache, hoarseness, sore throat.

Product Elements:

Viraclear eps 7630 cherry flavor pelargonium sidoides pelargonium sidoides root pelargonium sidoides root aronia melanocarpa fruit juice citric acid monohydrate alcohol fructose maltodextrin water potassium sorbate glycerin natural cherry flavor

Indications and Usage:

Indications and usage shortens duration and reduces severity of symptoms associated with common colds and throat/nasal/bronchial irritations: congestion, cough, headache, hoarseness, sore throat.

Warnings:

Warning sore throat warning : severe or persists sore throat for more than 2 days or if accompanied by high fever, headache, nausea, vomiting or rash may be serious. consult a doctor promptly. ask the doctor ask a doctor before use if you have a persistent or chronic cough that lasts, is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema have a cough that is accompanied by excessive phlegm (mucus) are taking any medications have an allergy to plants of the geraniaceae family stop use stop using and consult a doctor if new symptoms occur, symptoms get worse or do not get better within 7 days fever worsens or lasts more than 3 days cough lasts more than 7 days or occurs with rash or persistent headache. these could be signs of a serious condition. pregnancy if pregnant or breast-feeding, ask a healthcare professional before use. keep out of reach of children keep out of reach of children overdose in case of overdose, seek medical help or contact a poison control
center immediately.

Dosage and Administration:

Dosage & administration for best results, use at first sign of symptoms and continue to use for an additional 48 hours after symptoms cease. shake well before each use. use only with enclosed dosage cup. adults & children 13 years of age and older: take 1-1/2 teaspoons (tsp) (7.5 ml) three times daily. children 6-12 years of age: take 1 teaspoon (5 ml) three times daily. children under 6 years of age: consult a doctor

Stop Use:

Stop use stop using and consult a doctor if new symptoms occur, symptoms get worse or do not get better within 7 days fever worsens or lasts more than 3 days cough lasts more than 7 days or occurs with rash or persistent headache. these could be signs of a serious condition.

Use in Pregnancy:

Pregnancy if pregnant or breast-feeding, ask a healthcare professional before use.

Overdosage:

Overdose in case of overdose, seek medical help or contact a poison control center immediately.

Package Label Principal Display Panel:

Lbz780024_c03_vclear_cherry.jpg


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.